Atherosclerosis Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: A90843E523AAEN
Market Monitor Global

Abstracts

Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.

This report contains market size and forecasts of Atherosclerosis Therapeutics in Global, including the following market information:

Global Atherosclerosis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Atherosclerosis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Small Molecules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Atherosclerosis Therapeutics include AstraZeneca Plc, Bayer AG, Merck & Co. Inc., Novartis AG and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atherosclerosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Atherosclerosis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Atherosclerosis Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Small Molecules
• Biologics

Global Atherosclerosis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Atherosclerosis Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Research Institute
• Other

Global Atherosclerosis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Atherosclerosis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Atherosclerosis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Atherosclerosis Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca Plc
• Bayer AG
• Merck & Co. Inc.
• Novartis AG
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Atherosclerosis Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Atherosclerosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ATHEROSCLEROSIS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Atherosclerosis Therapeutics Market Size: 2021 VS 2028
2.2 Global Atherosclerosis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Atherosclerosis Therapeutics Players in Global Market
3.2 Top Global Atherosclerosis Therapeutics Companies Ranked by Revenue
3.3 Global Atherosclerosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Atherosclerosis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Atherosclerosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Atherosclerosis Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Atherosclerosis Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Atherosclerosis Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Atherosclerosis Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Small Molecules
  4.1.3 Biologics
4.2 By Type - Global Atherosclerosis Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Atherosclerosis Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Atherosclerosis Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Atherosclerosis Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Atherosclerosis Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Research Institute
  5.1.5 Other
5.2 By Application - Global Atherosclerosis Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Atherosclerosis Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Atherosclerosis Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Atherosclerosis Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Atherosclerosis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Atherosclerosis Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Atherosclerosis Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Atherosclerosis Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Atherosclerosis Therapeutics Revenue, 2017-2028
  6.3.2 US Atherosclerosis Therapeutics Market Size, 2017-2028
  6.3.3 Canada Atherosclerosis Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Atherosclerosis Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Atherosclerosis Therapeutics Revenue, 2017-2028
  6.4.2 Germany Atherosclerosis Therapeutics Market Size, 2017-2028
  6.4.3 France Atherosclerosis Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Atherosclerosis Therapeutics Market Size, 2017-2028
  6.4.5 Italy Atherosclerosis Therapeutics Market Size, 2017-2028
  6.4.6 Russia Atherosclerosis Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Atherosclerosis Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Atherosclerosis Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Atherosclerosis Therapeutics Revenue, 2017-2028
  6.5.2 China Atherosclerosis Therapeutics Market Size, 2017-2028
  6.5.3 Japan Atherosclerosis Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Atherosclerosis Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Atherosclerosis Therapeutics Market Size, 2017-2028
  6.5.6 India Atherosclerosis Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Atherosclerosis Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Atherosclerosis Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Atherosclerosis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Atherosclerosis Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Atherosclerosis Therapeutics Market Size, 2017-2028
  6.7.3 Israel Atherosclerosis Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Atherosclerosis Therapeutics Market Size, 2017-2028
  6.7.5 UAE Atherosclerosis Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca Plc
  7.1.1 AstraZeneca Plc Corporate Summary
  7.1.2 AstraZeneca Plc Business Overview
  7.1.3 AstraZeneca Plc Atherosclerosis Therapeutics Major Product Offerings
  7.1.4 AstraZeneca Plc Atherosclerosis Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Plc Key News
7.2 Bayer AG
  7.2.1 Bayer AG Corporate Summary
  7.2.2 Bayer AG Business Overview
  7.2.3 Bayer AG Atherosclerosis Therapeutics Major Product Offerings
  7.2.4 Bayer AG Atherosclerosis Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bayer AG Key News
7.3 Merck & Co. Inc.
  7.3.1 Merck & Co. Inc. Corporate Summary
  7.3.2 Merck & Co. Inc. Business Overview
  7.3.3 Merck & Co. Inc. Atherosclerosis Therapeutics Major Product Offerings
  7.3.4 Merck & Co. Inc. Atherosclerosis Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Merck & Co. Inc. Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Atherosclerosis Therapeutics Major Product Offerings
  7.4.4 Novartis AG Atherosclerosis Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Atherosclerosis Therapeutics Major Product Offerings
  7.5.4 Sanofi Atherosclerosis Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Atherosclerosis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Atherosclerosis Therapeutics Market Drivers in Global Market
Table 3. Atherosclerosis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Atherosclerosis Therapeutics in Global Market
Table 5. Top Atherosclerosis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Atherosclerosis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Atherosclerosis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Atherosclerosis Therapeutics Product Type
Table 9. List of Global Tier 1 Atherosclerosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Atherosclerosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Atherosclerosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Atherosclerosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Atherosclerosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Atherosclerosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Atherosclerosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Atherosclerosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Atherosclerosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Atherosclerosis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Atherosclerosis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Atherosclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Atherosclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Atherosclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Atherosclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Atherosclerosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Plc Corporate Summary
Table 31. AstraZeneca Plc Atherosclerosis Therapeutics Product Offerings
Table 32. AstraZeneca Plc Atherosclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bayer AG Corporate Summary
Table 34. Bayer AG Atherosclerosis Therapeutics Product Offerings
Table 35. Bayer AG Atherosclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Merck & Co. Inc. Corporate Summary
Table 37. Merck & Co. Inc. Atherosclerosis Therapeutics Product Offerings
Table 38. Merck & Co. Inc. Atherosclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Atherosclerosis Therapeutics Product Offerings
Table 41. Novartis AG Atherosclerosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Atherosclerosis Therapeutics Product Offerings
Table 44. Sanofi Atherosclerosis Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Atherosclerosis Therapeutics Segment by Type in 2021
Figure 2. Atherosclerosis Therapeutics Segment by Application in 2021
Figure 3. Global Atherosclerosis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Atherosclerosis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Atherosclerosis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Atherosclerosis Therapeutics Revenue in 2021
Figure 8. By Type - Global Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Atherosclerosis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Atherosclerosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Plc Atherosclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer AG Atherosclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck & Co. Inc. Atherosclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Atherosclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Atherosclerosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)